ClinicalTrials.govpublic full text
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
chronic myocardial ischemia, refractory angina pectoris, advanced coronary heart disease, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876993
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.